| Product NDC: | 0173-0383 |
| Proprietary Name: | ZANTAC |
| Non Proprietary Name: | ranitidine hydrochloride |
| Active Ingredient(s): | 15 mg/mL & nbsp; ranitidine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0173-0383 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019675 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19891001 |
| Package NDC: | 0173-0383-54 |
| Package Description: | 473 mL in 1 BOTTLE (0173-0383-54) |
| NDC Code | 0173-0383-54 |
| Proprietary Name | ZANTAC |
| Package Description | 473 mL in 1 BOTTLE (0173-0383-54) |
| Product NDC | 0173-0383 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ranitidine hydrochloride |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 19891001 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Strength Number | 15 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |